Search

everythinglearnresearchcommunity

for

Search:↓

TrichoFoam™ is a stable option for personalized hair loss treatment with most ingredients remaining effective for 90-180 days.

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

Higher childhood DHEAS levels are linked to advanced puberty and DNA changes.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Scalp hair 17-OHP and androstenedione levels can help monitor treatment in CAH patients.

Hair levels of estradiol and progesterone are higher in premenopausal than postmenopausal women, but the difference isn't statistically significant, indicating the need for a better measurement method.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

TrichoSol™ effectively stabilizes various hair treatment ingredients for different durations.

The method accurately measures testosterone metabolites with high sensitivity and low environmental impact.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

PPCM microspheres can effectively release finasteride over 42 days.

The method is quick and effective for testing steroid 5 alpha-reductase inhibitors.

MK-386 reduces sebum DHT levels.

Cyproterone acetate is an effective treatment for women with acne, hair loss, and excessive hair growth.

Tiny lipid particles loaded with a hormone gather in hair follicles, which may help treat hair loss.

Chronic DHEA supplementation slightly increases testosterone in hair but stays within safe limits.

Female guinea pigs exposed to less allopregnanolone before birth showed more anxiety-like behavior.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Dexamethasone increases the activity of androgen receptors in human skin cells, which may link it to certain types of hair loss.

Monitoring steroid hormones in blood can better detect testosterone doping.

Pregnancies in a woman with the Donohue mutation were managed with genetic testing, resulting in three healthy infants.

Hormonal contraceptives are highly effective but require medical evaluation due to potential health risks.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Both Diane 35 combinations effectively and safely reduce hirsutism and acne, with potential for better results if treatment extends beyond 12 months.

Higher DHEA-S levels are linked to smaller ovarian volume in women with PCOS.